Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuanhao Chang

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancer Medicine|December 19, 2019
Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all agesGuanzhang Li, You Zhai, Zheng Wang, et al.
Bioscience Reports|December 16, 2020
Uronic acid metabolic process-related gene expression-based signature predicts overall survival of gliomaYuemei Feng, Guanzhang Li, Zhongfang Shi, et al.
Scientific Reports|November 24, 2020
A novel methylation signature predicts radiotherapy sensitivity in gliomaYuemei Feng, Guanzhang Li, Zhongfang Shi, et al.
Aging|July 24, 2020
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastomaGuanzhang Li, You Zhai, Hanjie Liu, et al.
Frontiers in Cell and Developmental Biology|December 16, 2021
Molecular Characterization and Clinical Relevance of <i>ANXA1</i> in Gliomas <i>via</i> 1,018 Chinese Cohort PatientsZenghui Qian, Wenhua Fan, Fanlin Meng, et al.
Redox Biology|September 6, 2025
Novel Thioredoxin reductase 1 inhibitor BS1801 relieves treatment resistance and triggers endoplasmic reticulum stress by elevating reactive oxygen species in gliomaYuanhao Chang, Jin Chang, Jiayu Ji, et al.
Cancer Science|December 9, 2021
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samplesWang Di, Wenhua Fan, Fan Wu, et al.
CNS Neuroscience & Therapeutics|March 1, 2021
High-sensitive clinical diagnostic method for PTPRZ1-MET and the characteristic protein structure contributing to ligand-independent MET activationRuoyu Huang, Yanwei Liu, Kuanyu Wang, et al.
Frontiers in Immunology|December 27, 2021
Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q CodeletionGuanzhang Li, Ruoyu Huang, Wenhua Fan, et al.
Aging|May 13, 2020
<i>EFEMP2</i> indicates assembly of M0 macrophage and more malignant phenotypes of gliomaLijie Huang, Zheng Wang, Yuanhao Chang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Medicine|December 19, 2019
Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all agesGuanzhang Li, You Zhai, Zheng Wang, et al.
Bioscience Reports|December 16, 2020
Uronic acid metabolic process-related gene expression-based signature predicts overall survival of gliomaYuemei Feng, Guanzhang Li, Zhongfang Shi, et al.
Scientific Reports|November 24, 2020
A novel methylation signature predicts radiotherapy sensitivity in gliomaYuemei Feng, Guanzhang Li, Zhongfang Shi, et al.
Aging|July 24, 2020
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastomaGuanzhang Li, You Zhai, Hanjie Liu, et al.
Frontiers in Cell and Developmental Biology|December 16, 2021
Molecular Characterization and Clinical Relevance of <i>ANXA1</i> in Gliomas <i>via</i> 1,018 Chinese Cohort PatientsZenghui Qian, Wenhua Fan, Fanlin Meng, et al.
Redox Biology|September 6, 2025
Novel Thioredoxin reductase 1 inhibitor BS1801 relieves treatment resistance and triggers endoplasmic reticulum stress by elevating reactive oxygen species in gliomaYuanhao Chang, Jin Chang, Jiayu Ji, et al.
Cancer Science|December 9, 2021
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samplesWang Di, Wenhua Fan, Fan Wu, et al.
CNS Neuroscience & Therapeutics|March 1, 2021
High-sensitive clinical diagnostic method for PTPRZ1-MET and the characteristic protein structure contributing to ligand-independent MET activationRuoyu Huang, Yanwei Liu, Kuanyu Wang, et al.
Frontiers in Immunology|December 27, 2021
Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q CodeletionGuanzhang Li, Ruoyu Huang, Wenhua Fan, et al.
Aging|May 13, 2020
<i>EFEMP2</i> indicates assembly of M0 macrophage and more malignant phenotypes of gliomaLijie Huang, Zheng Wang, Yuanhao Chang, et al.
Pageof 2